News Praxis soars on rare childhood epilepsy trial data Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.
News Wearable alert system for epileptics set for European launch An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.
News Angelini taps Sovargen for epilepsy drug in $550m deal Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy.
R&D Navigating the unique challenges of epilepsy in women's heal... Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.
News Case builds for Biogen, Stoke's Dravet syndrome drug Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen.
News AI tool detects brain lesions linked to epilepsy Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.